63 citations
,
February 2024 in “BMC Psychology” Emotion recognition tech helps devices understand emotions, but more research is needed for complex situations.
November 2023 in “Australasian journal of dermatology” Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.
Oral minoxidil may have more cardiovascular risks than topical minoxidil.
1647 citations
,
June 2014 in “BMJ” Evidence-based medicine needs improvement to better tailor treatments to individual patients.
5 citations
,
January 2024 in “BMC Cancer” Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.
June 2025 in “British Journal of Dermatology” Melanocytic matricoma can look like skin cancer but is usually harmless; surgery and follow-up are advised.
March 2025 in “Journal of Cosmetic Dermatology” Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.
14 citations
,
September 2023 in “The Medical Journal of Australia” Telemedicine in Australia is growing, but concerns about quality and integration with traditional care remain.
March 2026 in “The American Journal of Managed Care” JAK inhibitors can help treat alopecia areata but have risks and high costs.
May 2024 in “IntechOpen eBooks” More oxygen isn't always better and can sometimes be worse.
7 citations
,
October 2020 in “Dermatology practical & conceptual” Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.
January 2017 in “Journal of Investigative Dermatology Symposium Proceedings” The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.
Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.
400 citations
,
January 2014 in “British Journal of Sports Medicine” The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.
122 citations
,
August 2020 in “Tropical Diseases Travel Medicine and Vaccines” COVID-19 severely affects older adults with chronic heart, lung, or metabolic diseases.
7 citations
,
March 2023 in “Pharmacy” Pharmacist-led care significantly improved post-COVID symptoms.
1 citations
,
January 2021 in “IntechOpen eBooks” Herbal remedies like Asparagus racemosus and Tinospora cordifolia may help manage PCOS symptoms.
July 2025 in “Indian Journal of Endocrinology and Metabolism” The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.
May 2023 in “Journal of managed care & specialty pharmacy” Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.
July 2016 in “Biometrics & Biostatistics International Journal” New guidelines using video aim to ensure honest reporting of hair loss treatments.
112 citations
,
July 2020 in “BMC Medicine” Women with PCOS may be at higher risk for severe COVID-19.
39 citations
,
June 2023 in “Advanced Materials” Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.
25 citations
,
June 2023 in “Biomedicines” Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.
2 citations
,
April 2025 in “BMC Infectious Diseases” Long COVID affects about 27% of patients, with higher risk for women, lower education, and certain income levels.
2 citations
,
October 2020 in “Journal of Pharmacy And Bioallied Sciences” Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.
October 2025 in “Frontiers in Medicine” Ixekizumab has known and some unexpected side effects.
March 2025 in “International Journal of Trichology” Dermatologists should address discrimination and consider ethnic and gender differences in treatments.
6 citations
,
April 2021 in “Journal of Mind and Medical Sciences” Most women preferred and recommended vaginal birth over Caesarean.
March 2026 in “Annals of Medicine” Standardized tools and treatments are needed to better manage long COVID-19 in kids and teens.
Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.